芬兰人群中富集的新型 LAMC3 致病变体会导致大脑皮层发育畸形和严重癫痫。

IF 16.4 1区 化学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Anni Saarela, Oskari Timonen, Jarkko Kirjavainen, Yawu Liu, Katri Silvennoinen, Esa Mervaala, Reetta Kälviäinen
{"title":"芬兰人群中富集的新型 LAMC3 致病变体会导致大脑皮层发育畸形和严重癫痫。","authors":"Anni Saarela,&nbsp;Oskari Timonen,&nbsp;Jarkko Kirjavainen,&nbsp;Yawu Liu,&nbsp;Katri Silvennoinen,&nbsp;Esa Mervaala,&nbsp;Reetta Kälviäinen","doi":"10.1002/epd2.20244","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>Recessive <i>LAMC3</i> mutations are recognized to cause epilepsy with cortical malformations characterized by polymicrogyria and pachygyria. The objective of this study was to describe the clinical picture and epilepsy phenotype of four patients with a previously undescribed <i>LAMC3</i> variant.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>All epilepsy patients treated in Kuopio Epilepsy Center (located in Kuopio, Finland) are offered the possibility to participate in a scientific study investigating biomarkers in epilepsy (Epibiomarker study). We have collected a comprehensive database of the study population, and are currently re-evaluating our database regarding the patients with developmental and/or epileptic encephalopathy (DEE). If the etiology of epilepsy remains unknown in the clinical setting, we are performing whole exome sequencing to recognize the genetic causes.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Among our study population of 323 DEE patients we recognized three patients with similar homozygous <i>LAMC3</i> c.1866del (p.(Phe623Serfs*10)) frameshift variant and one patient with a compound heterozygous mutation where the same frameshift variant was combined with an intronic <i>LAMC3</i> c.4231-12C&gt;G variant on another allele. All these patients have severe epilepsy and either bilateral agyria-pachygyria or bilateral polymicrogyria in their clinical MRI scanning. Cortical malformations involve the occipital lobes in all our patients. Epilepsy phenotype is variable as two of our patients have DEE with epileptic spasms progressing to Lennox–Gastaut syndrome and intellectual disability. The other two patients have focal epilepsy without marked cognitive deficit. The four patients are unrelated. <i>LAMC3</i> c.1866del p.(Phe623Serfs*10) frameshift variant is enriched in the Finnish population.</p>\n </section>\n \n <section>\n \n <h3> Significance</h3>\n \n <p>Only a few patients with epilepsy caused by <i>LAMC3</i> homozygous or compound heterozygous mutations have been described in the literature. To our knowledge, the variants discovered in our patients have not previously been published. Clinical phenotype appears to be more varied than previously assumed and patients with a milder phenotype and normal cognition have probably remained unrecognized.</p>\n </section>\n </div>","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/epd2.20244","citationCount":"0","resultStr":"{\"title\":\"Novel LAMC3 pathogenic variant enriched in Finnish population causes malformations of cortical development and severe epilepsy\",\"authors\":\"Anni Saarela,&nbsp;Oskari Timonen,&nbsp;Jarkko Kirjavainen,&nbsp;Yawu Liu,&nbsp;Katri Silvennoinen,&nbsp;Esa Mervaala,&nbsp;Reetta Kälviäinen\",\"doi\":\"10.1002/epd2.20244\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Objective</h3>\\n \\n <p>Recessive <i>LAMC3</i> mutations are recognized to cause epilepsy with cortical malformations characterized by polymicrogyria and pachygyria. The objective of this study was to describe the clinical picture and epilepsy phenotype of four patients with a previously undescribed <i>LAMC3</i> variant.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>All epilepsy patients treated in Kuopio Epilepsy Center (located in Kuopio, Finland) are offered the possibility to participate in a scientific study investigating biomarkers in epilepsy (Epibiomarker study). We have collected a comprehensive database of the study population, and are currently re-evaluating our database regarding the patients with developmental and/or epileptic encephalopathy (DEE). If the etiology of epilepsy remains unknown in the clinical setting, we are performing whole exome sequencing to recognize the genetic causes.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Among our study population of 323 DEE patients we recognized three patients with similar homozygous <i>LAMC3</i> c.1866del (p.(Phe623Serfs*10)) frameshift variant and one patient with a compound heterozygous mutation where the same frameshift variant was combined with an intronic <i>LAMC3</i> c.4231-12C&gt;G variant on another allele. All these patients have severe epilepsy and either bilateral agyria-pachygyria or bilateral polymicrogyria in their clinical MRI scanning. Cortical malformations involve the occipital lobes in all our patients. Epilepsy phenotype is variable as two of our patients have DEE with epileptic spasms progressing to Lennox–Gastaut syndrome and intellectual disability. The other two patients have focal epilepsy without marked cognitive deficit. The four patients are unrelated. <i>LAMC3</i> c.1866del p.(Phe623Serfs*10) frameshift variant is enriched in the Finnish population.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Significance</h3>\\n \\n <p>Only a few patients with epilepsy caused by <i>LAMC3</i> homozygous or compound heterozygous mutations have been described in the literature. To our knowledge, the variants discovered in our patients have not previously been published. Clinical phenotype appears to be more varied than previously assumed and patients with a milder phenotype and normal cognition have probably remained unrecognized.</p>\\n </section>\\n </div>\",\"PeriodicalId\":1,\"journal\":{\"name\":\"Accounts of Chemical Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":16.4000,\"publicationDate\":\"2024-05-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/epd2.20244\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Accounts of Chemical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/epd2.20244\",\"RegionNum\":1,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/epd2.20244","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

摘要

目的:隐性 LAMC3 基因突变被认为可导致癫痫,并伴有皮质畸形,其特征为多小脑和小脑畸形。本研究的目的是描述四名以前未曾描述过的LAMC3变异体患者的临床表现和癫痫表型:所有在库奥皮奥癫痫中心(位于芬兰库奥皮奥)接受治疗的癫痫患者都有可能参加一项调查癫痫生物标志物的科学研究(Epibiomarker 研究)。我们已经收集了研究人群的综合数据库,目前正在重新评估有关发育性和/或癫痫性脑病(DEE)患者的数据库。如果临床上癫痫的病因仍然不明,我们将进行全外显子组测序,以确认遗传原因:结果:在我们研究的323名DEE患者中,我们发现3名患者具有相似的同源LAMC3 c.1866del (p.(Phe623Serfs*10)) 框移变异,1名患者具有复合杂合突变,即同一框移变异与另一等位基因上的内含LAMC3 c.4231-12C>G变异相结合。所有这些患者都患有严重的癫痫,临床核磁共振扫描结果显示,他们要么患有双侧虹膜畸形,要么患有双侧多虹膜畸形。所有患者的皮质畸形均累及枕叶。癫痫的表型多种多样,其中两名患者患有伴有癫痫痉挛的 DEE,并发展为 Lennox-Gastaut 综合征和智力残疾。另外两名患者为局灶性癫痫,无明显认知障碍。这四名患者没有亲属关系。LAMC3 c.1866del p.(Phe623Serfs*10) 框移变异在芬兰人群中富集:文献中仅描述了少数由 LAMC3 同源或复合杂合变异引起的癫痫患者。据我们所知,在我们的患者中发现的变异以前从未发表过。临床表型似乎比以前假定的更为多样,表型较轻且认知能力正常的患者可能仍未被认识到。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Novel LAMC3 pathogenic variant enriched in Finnish population causes malformations of cortical development and severe epilepsy

Novel LAMC3 pathogenic variant enriched in Finnish population causes malformations of cortical development and severe epilepsy

Objective

Recessive LAMC3 mutations are recognized to cause epilepsy with cortical malformations characterized by polymicrogyria and pachygyria. The objective of this study was to describe the clinical picture and epilepsy phenotype of four patients with a previously undescribed LAMC3 variant.

Methods

All epilepsy patients treated in Kuopio Epilepsy Center (located in Kuopio, Finland) are offered the possibility to participate in a scientific study investigating biomarkers in epilepsy (Epibiomarker study). We have collected a comprehensive database of the study population, and are currently re-evaluating our database regarding the patients with developmental and/or epileptic encephalopathy (DEE). If the etiology of epilepsy remains unknown in the clinical setting, we are performing whole exome sequencing to recognize the genetic causes.

Results

Among our study population of 323 DEE patients we recognized three patients with similar homozygous LAMC3 c.1866del (p.(Phe623Serfs*10)) frameshift variant and one patient with a compound heterozygous mutation where the same frameshift variant was combined with an intronic LAMC3 c.4231-12C>G variant on another allele. All these patients have severe epilepsy and either bilateral agyria-pachygyria or bilateral polymicrogyria in their clinical MRI scanning. Cortical malformations involve the occipital lobes in all our patients. Epilepsy phenotype is variable as two of our patients have DEE with epileptic spasms progressing to Lennox–Gastaut syndrome and intellectual disability. The other two patients have focal epilepsy without marked cognitive deficit. The four patients are unrelated. LAMC3 c.1866del p.(Phe623Serfs*10) frameshift variant is enriched in the Finnish population.

Significance

Only a few patients with epilepsy caused by LAMC3 homozygous or compound heterozygous mutations have been described in the literature. To our knowledge, the variants discovered in our patients have not previously been published. Clinical phenotype appears to be more varied than previously assumed and patients with a milder phenotype and normal cognition have probably remained unrecognized.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Accounts of Chemical Research
Accounts of Chemical Research 化学-化学综合
CiteScore
31.40
自引率
1.10%
发文量
312
审稿时长
2 months
期刊介绍: Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信